APA (7th ed.) Citation

Gupta, A. S., MacEwan, J. P., Anderson, J., Zhao, X., Kim, S., Surinach, A., . . . Chen, X. (2026). Real-World, Long-Term Outcomes with Cladribine Tablets Versus Other Oral Treatments Among Patients with Multiple Sclerosis. Neurology & Therapy, 15(4), 2041. https://doi.org/10.1007/s40120-026-00968-2

Chicago Style (17th ed.) Citation

Gupta, Ajay S., Joanna P. MacEwan, Jeffrey Anderson, Xin Zhao, Sonia Kim, Andy Surinach, Yu Hong, Amy L. Phillips, and Xiaoxue Chen. "Real-World, Long-Term Outcomes with Cladribine Tablets Versus Other Oral Treatments Among Patients with Multiple Sclerosis." Neurology & Therapy 15, no. 4 (2026): 2041. https://doi.org/10.1007/s40120-026-00968-2.

MLA (9th ed.) Citation

Gupta, Ajay S., et al. "Real-World, Long-Term Outcomes with Cladribine Tablets Versus Other Oral Treatments Among Patients with Multiple Sclerosis." Neurology & Therapy, vol. 15, no. 4, 2026, p. 2041, https://doi.org/10.1007/s40120-026-00968-2.